Literature DB >> 18438922

Maternal immune activation in mice delays myelination and axonal development in the hippocampus of the offspring.

Manabu Makinodan1, Kouko Tatsumi, Takayuki Manabe, Takahira Yamauchi, Eri Makinodan, Hiroko Matsuyoshi, Shigero Shimoda, Yoshinobu Noriyama, Toshifumi Kishimoto, Akio Wanaka.   

Abstract

Epidemiological data suggest a relationship between maternal infection and a high incidence of schizophrenia in offspring. An animal model based on this hypothesis was made by injecting double-stranded RNA, polyinosinic-polycytidylic acid (poly-I:C), into early pregnant mice, and their offspring were examined for biochemical and histological abnormalities. Mouse brains were examined with special reference to oligodendrocytes, which have been implicated in several neurodevelopmental disorders. We detected a significant decrease of myelin basic protein (MBP) mRNA and protein at early postnatal periods in poly-I:C mice. MBP immunocytochemistry and electron microscopy revealed that the hippocampus of juvenile poly-I:C mice was less myelinated than in PBS mice, with no significant loss of oligodendrocytes. In addition, axonal diameters were significantly smaller in juvenile poly-I:C mice than in control mice. These abnormalities reverted to normal levels when the animals reached the adult stage. These findings suggest that retarded myelination and axonal abnormalities in early postnatal stages caused by maternal immune activation could be related to schizophrenia-related behaviors in adulthood.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18438922     DOI: 10.1002/jnr.21673

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  29 in total

1.  Impact of prenatal immune challenge on the demyelination injury during adulthood.

Authors:  Abdeslam Mouihate; Hessah Al-Hashash; Sarah Rakhshani-Moghadam; Samah Kalakh
Journal:  CNS Neurosci Ther       Date:  2017-07-17       Impact factor: 5.243

2.  Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia.

Authors:  Yael Piontkewitz; Michal Arad; Ina Weiner
Journal:  Schizophr Bull       Date:  2010-05-03       Impact factor: 9.306

Review 3.  Maternal immune activation and abnormal brain development across CNS disorders.

Authors:  Irene Knuesel; Laurie Chicha; Markus Britschgi; Scott A Schobel; Michael Bodmer; Jessica A Hellings; Stephen Toovey; Eric P Prinssen
Journal:  Nat Rev Neurol       Date:  2014-10-14       Impact factor: 42.937

4.  The neurobiology of transition to psychosis: clearing the cache.

Authors:  Lena Palaniyappan; Tushar Das; Kara Dempster
Journal:  J Psychiatry Neurosci       Date:  2017-09       Impact factor: 6.186

5.  PRENATAL INFECTION, MATERNAL IMMUNE ACTIVATION, AND RISK FOR SCHIZOPHRENIA.

Authors:  Sarah E Canetta; Alan S Brown
Journal:  Transl Neurosci       Date:  2012-12-01       Impact factor: 1.757

6.  Activation of the maternal immune system induces endocrine changes in the placenta via IL-6.

Authors:  Elaine Y Hsiao; Paul H Patterson
Journal:  Brain Behav Immun       Date:  2010-12-30       Impact factor: 7.217

Review 7.  Prenatal programing: at the intersection of maternal stress and immune activation.

Authors:  Christopher L Howerton; Tracy L Bale
Journal:  Horm Behav       Date:  2012-03-23       Impact factor: 3.587

Review 8.  Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models.

Authors:  Hanna Jaaro-Peled; Yavuz Ayhan; Mikhail V Pletnikov; Akira Sawa
Journal:  Schizophr Bull       Date:  2009-11-10       Impact factor: 9.306

9.  Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia.

Authors:  Li-Jin Chew; Paolo Fusar-Poli; Thomas Schmitz
Journal:  Dev Neurosci       Date:  2013-02-27       Impact factor: 2.984

Review 10.  Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?

Authors:  P Steullet; J H Cabungcal; A Monin; D Dwir; P O'Donnell; M Cuenod; K Q Do
Journal:  Schizophr Res       Date:  2014-07-05       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.